BACKGROUND. The objective of this study was to update the registry of women in the Netherlands with clear cell adenocarcinoma (CCAC) of the cervix or vagina with or without intrauterine exposure to diethylstilbestrol (DBS), METHODS. Ftom a nationwide search in PALGA, the automated pathology registry in the Netherlands, data were gathered on women with CCAC born after 1947. Information obtained from the clinical files of the patients included reported expo sure to DES, patterns of complaints previous to diagnosis, the current status of the patients, and the results of cytopathologic examinations previous to histopath ologic diagnosis. After review of the histopadiologic slides, the specific pathologic characteristics of CCAC were determined. The age distribution of women born after 1947 was compared with that of women born before 1947. RESULTS. Information about possible exposure to DES during pregnancy was avail able for 73 of 88 women with CCAC born after 1947. Exposure to DES was reported for 47 (64%) of these women. The DES medication was most often reported as having started before the 18th week of pregnancy. Cytopathologic examination was informative in 81% of the cases of CCAC of the cervix, but only in 41% of the cases of CCAC of the vagina. Most patients had Stage I or II tumors at diagnosis. Tumor Stage III and IV and a high grade of nuclear atypia were related to unfavor able outcome, The age distribution of all patients with CCAC showed two distinct peaks: one at young age, [a mean age of 26 years), and one at older age (a mean age of 71 years). This bimodal age distribution still applied when the cases in which DES exposure was reported had been excluded. CONCLUSIONS. Despite the fact that DES has not been prescribed to pregnant women in the Netherlands in the last 20 years, CCAC is still relevant in our times. It is important to stay alert and periodically to update and evaluate the data of this registry, including data on women born outside the DES exposure period. The bimodal age distribution in this study of women without intrauterine exposure to DES suggests a carcinogenesis-promoting role of menarche and menopause and I or the existence of a subpopulation with genetic risk factors or exogenous risk factors other than exposure to DES. Postmenopausal observation of women ex posed to DES must be encouraged for clinical reasons and may help facilitate differentiation between these two hypotheses. If these risk factors of CCAC were better documented and their interrelationships better defined, CCAC could be come an important model of multistep carcinogenesis in tissues sensitive to sex hormones. C ancer 1997;79:2229-36. © 1997 A m erican Cancer Society.
S ince a publication in 1971 by H erbst et al, several studies have linked the occurrence of vaginal clear cell adenocarcinom a (CCAC) in young w om en w ith intrauterine exposure to the synthetic nonste roid estrogenic horm one Diethylstilbestrol (DES).1 DES has been pre scribed in several countries to pregnant w om en as a preventive ther-apy against abortion.2 Based on crude estimates of exposure and sales, it has been estim ated that in the U. S. 1 to 4 million w om en have used DES during preg nancy.3 Melnick et al estim ated that the chance of developing a CCAC is 1 in 1000 for DES-exposed women.4 Until 1989, the central American voluntary registiy had registered 547 patients with CCAC; in 60% of those cases, the m other was reported as having used DES during pregnancy,5 However, the absence of cases of CCAC in prospective cohort studies, its occurrence at an apparently similar rate in Norway (a country in which DES was not available6), and biases in the stud ies incriminating DES have led other epidem iologists to question the relation betw een DES and CCAC.7 In the Netherlands, DES was prescribed from 1947 until 1975.a Previous publications have exam ined the occur rence of CCAC in the Netherlands.9,10 Until January 1, 1982 in the Netherlands, 21 patients were known to have CCAC.9 Of these, 16 m others were reported as having used DES (76%). In 1991 the results of a study of 55 Dutch CCAC patients diagnosed before July 1, 1988 were published; DES exposure was reported in 63% of the patients with data on maternal history. 10 The total consum ption of DES in the Netherlands can not be traced* This can be attributed to the multitude of companies distributing DES in the Netherlands; moreover, pharmacists work with bulk products rather than with individual factory packaging. The Dutch DES Action and Information Center has estim ated that 189,000 to 378,000 w om en w ould have been exposed to DES during their mother's pregnancy. 8 The objective of the current descriptive study was to update, through June 1993, the epidem iologic, clini cal, and pathologic data o f w om en with CCAC of the vagina or cervix. Attention was given to the incidence of the tumor, DES exposure, the significance of cytopathologic examination for the early detection of this disease, signs and sym ptom s discovered previous to the diagnosis, prognostic parameters, and the age of the patients. In addition, the nationwide com pleteness of pathologic records since 1988 in the Netherlands also allowed the registration of cases o f CCAC in women born before 1947, before DES was prescribed in the Netherlands.
PATIENTS AND METHODS
For the registry update, an inventory was made of all patients with a diagnosis of CCAC of the cervix and/ or vagina who were born after 1947. For this purpose, a nationwide search was perform ed in the automated pathology archive, PALGA. Since 1988, all Depart ments of Pathology in the Netherlands have been co n nected to the PALGA com puter network. The results of the nationwide search indicated in which Depart m ents of Pathology the diagnoses of CCAC of the cer vix and/or vagina had been made. The involved de partments were asked for a copy of the report of the histopathologic examination. If the patient was al ready known from a previous evaluation, the new in formation was added to the known data. If a patient was born after 1947 and had not yet been registered at the Central Netherlands Registry (CNR) for CCAC, the patient was registered after transfer of a signed declaration of approval of scientific research. The CNR received declarations from som e patients via the Dutch DES Action and Information Center, and for the remaining patients via their gynecologists.
The relevant histologic slides of the selected pa tients were reviewed by two pathologists (A.H. and J.B.). If the diagnosis of CCAC was confirmed, a stan dard questionnaire requesting the following data was sent by the researchers (A.H., M.L., O.S.) to the pa tient's doctors, who were asked to consult their clinical files: the year of diagnosis, presence or absence of intrauterine DES exposure, reason for DES prescrip tion, localization and stage of the tumor, treatment for CCAC, patient's use of contraception, signs and symptoms before the diagnosis, and current status of the patients. The following data of the patients who were already known at the CNR before 1988 were re corded: current status, presence of recurrence or m e tastasis, supplementary therapy, date of last examina tion, and more recent information concerning intra uterine DES exposure.
At histopathologic review, the following character istics were registered: tumor localization within the cervix or vagina, size of the tumor, mitotic activity, grade of nuclear atypia, and histologic growth pattern. The mitotic activity was defined as the number of mi toses per 10 high-power fields (HPF = objective X40), The grade of nuclear atypia was determined according the criteria of Christopherson et al,11 based on the shape and size of the nuclei, the presence and shape of nucleoli, and the chromatin pattern. The growth pattern of CCAC in this study was classified as: pre dominantly tubulocystic, solid, papillary, or mixed. Based on the PALGA data of the selected women, the results of cytopathologic examination of vagina and/ or cervix (performed up to 2 years before the histo pathologic diagnosis) were also recorded.
Because DES was not prescribed in the Nether lands until 1947,° and until the time of study the CNR had focused on DES-associated pathology, no patients registered in the CNR had been born before 1947. However, for this study cases of patients born before 1947 who had a diagnosis of CCAC after 1988 could be registered because by that time the PALGA was com pletely nationwide. 
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RESULTS
Incidence of CCAC in Women Born after 1947
As a result of the nationwide search in PALGA, it ap peared that since the last evaluation of the CNR in 1988 CCAC had been diagnosed in 27 patients born after 1947. One patient from Suriname, who had stayed in the Netherlands for 3 m onths for treatment of her CCAC, was excluded from the current evalua tion. Another seven patients were included, two pa tients for whom the CNR did not have all data available in 1988, and two new patients who had been reported by their gynecologists to the CNR during the current evaluation. Histopathologic review o f the slides of three patients who were not known at PALGA but who were known at the DES Action and Information Center confirmed the presence of CCAC. Together with the 55 patients who were known in 1988, the registry as of May 1993 included data from 88 w om en with CCAC. All tumors of these 88 patients had been diagnosed between 1969 and 1993. The highest incidence (ten women) occurred in 1988. Thereafter, the incidence appeared to decrease, but more tim e is necessaiy to elapse before this can be ascertained. The oldest pa tient was born in 1947, and the youngest in 1973. The year in which the m ost w om en (n = 10) with CCAC were born was 1960.
DES Exposure
Maternal information of intrauterine DES exposure could be obtained from 73 of 88 patients born after 1947. This information was obtained from the m edical records or in som e cases from questionnaires returned by the gynecologists (n = 64) or the general prac titioners (n = 7) of the CCAC patients. In two cases, statements of DES exposure were received through declarations of the patients them selves to the DES Ac tion and Information Center. In 47 of the 73 patients with information on maternal history (64%), it was stated that they had been exposed to DES. In 20 pa tients (27%) no report of exposure to DES was given. For 6 patients (8%) it was not known whether the mother had used DES during the pregnancy. A reason for DES prescription was given in 25 of the 47 w om en reported as having been exposed to DES. The m ost frequent reason (n = 15) was that the mother had had difficulties in a previous pregnancy, such as abortion or threatened abortion and abnormal blood loss.
Of the 47 reportedly DES-exposed patients, the majority (29 patients; 62%) had carcinoma o f the v a gina (possibly with extension to the ectocervix, but not to the endocervix); 18 (38%) patients had a CCAC of the cervix. Of the 20 patients with a negative DES h is tory, approximately two-thirds (14 patients; 70%) had a CCAC of the cervix.
Data on the point in the pregnancy at which DES m edication was reportedly started could be obtained from 30 patients. In 21 patients DES was reported as having b een used before the 18th week, in 8 patients it was believed to be prescribed before the 18th week, and in 1 patient it was prescribed after the 18th week of pregnancy.
Cytologic Examination
Of the group of 88 young patients with CCAC, cytologic exam ination had b een perform ed in 49% (43 patients) within 2 years before the histologic diagnosis. Of these 43 patients, 28 w om en (65%) had a "positive" cyto logic diagnosis ("suspected m alignant" or "malig nant") and 15 patients (35%) had a "negative" cyto logic diagnosis ("no abnormalities" or "atypia"). The percentage of detected carcinom as of the cervix was higher than that of the vagina. Tw enty-one of the 26 patients with a cervical carcinom a (81%) and 7 of the 17 patients with a CCAC of the vagina (41%) had a "positive" cytologic diagnosis. Figure 1 . The youngest patient teristics. The percentage of patients who died corre-was age 8 years and the oldest 37 years. The mean age lated with higher stages (Table 1 ). There was no clear was 23.6 years. The age of DES-exposed wom an ranged difference in tumor stage betw een patients with or from 14 years to 37 years with a mean age of 21.3 without DES exposure. No data on survival were years. The youngest patient who had not been exposed known for three patients. For two patients, a complete to DES was age 18 years at diagnosis and the oldest revision of the histologic slides was not possible. Ta (12 patients) . The same ratio applied for the younger wom en who had not been exposed to DES or w hose DES histoiy was unknown. Two-thirds of the young wom en who had been exposed to DES had a CCAC of the vagina (11 patients), and one-third of the patients had CCAC of the cervix (5 patients). 
Signs and Symptoms
------- 1 (50%) ------- Mixed 17 (100%) 4 (24%) 4 (24%) 8 (47%) 1(6%) Unknown 2 (100%) ------- 1 (50%) 1 (50%) -------
DISCUSSION
In this overview the epidem iologic, clinical, and histo pathologic characteristics have been described in a group of 88 Dutch w om en born after January 1947 with a CCAC of the cervix or vagina diagnosed before May 1993. The increase in th e number of young w om en diagnosed with CCAC since 1970 that has been described in the American literature1 appears also to have taken place in the Netherlands. However, one cannot be certain of this in the U.S., because the Amer ican registry has remained on a voluntary basis. Even w hen the registry was population-based, as in the state of Connecticut, it appeared that half of the CCAC cases had not been diagnosed as su ch .13 A fortiori, underdi agnosis can be suspected in cases diagnosed before 1971. Also in the Netherlands, previous and possibly even recent underdiagnosis remains possible because PALGA includes only all patients diagnosed since 1988 and because it cannot be excluded that some CCACs are hidden under the diagnosis of "adenocarcinoma'-' or "carcinoma." Given the notoriety of a DES-CCAC relationship, it is quite possible that cases without re ported exposure to DES have failed to be diagnosed as CCAC, but this could be ascertained only by a dedi cated study of all vaginal and cervical tumors. From the current registry data, it appears that in 1988 the highest number of patients with CCAC were diagnosed and that the incidence appeared to decrease thereaf ter. The highest incidence in the U. S. was observed in 1975.5 The recent higher incidence in the Netherlands corresponds with a later birth peak of the DES-exposed Dutch patients.10 It also is possible that the different setup of the registry in the U.S., based on a voluntary entry, and the possibility of previous under diagnosis, have contributed to the differences between the data in the U.S. and the Netherlands. In the current Dutch registry, 47 of the 73 women with data on maternal histoiy (64%) had, according to the authors' information, been exposed to DES. This percentage is comparable to that of the previous Dutch report on data until 1988 (63%), the registry of the U. S. in 1989 (60%), and two French series.5,10* 14,15 In the current study, 99% of wom en whose physician had information concerning the time of DES exposure had been exposed to DES before the 18th week of pregnancy. The most frequent reasons for DES being prescribed to the patients' mothers were problems in previous pregnancies, such as abortion or threatened abortion and abnormal blood loss.
The results of the cytologic examination showed a diagnosis of "malignant" or "suspected malignant" disease in 81% of the patients with cervical carcinoma and in 41% of patients with vaginal carcinoma. These results are similar to previous findings of the CNR in 1988.10 Only cervical smears and no vaginal smears had been taken in those cases of CCAC of the vagina that had a cytologic diagnosis of "no abnormalities" or "atypia." This supports earlier observations that cytologic examination can make an important contri bution to the diagnosis of CCAC if the smear-taking procedure is performed well, i.e., is comprised of sepa rate smears from the cervix and from the four quad rants of the vagina.
Comparing the current findings with previous reg istry analysis, it appears that patients are increasingly being diagnosed at an earlier stage and after a shorter time interval between report of symptoms and diagno sis.9,10 The patients who have been diagnosed since 1988 more often had a Stage I tum or (59%) than the patients who were entered in the registry before 1988 (31%). Since 1988, more patients (82%) had reported no symptoms at diagnosis, or reported symptoms of < 6 months' duration, than before 1988 (53%). This suggests that secondary prevention measures were successful.
Important parameters for the determination o f prognosis of CCAC patients are stage, tumor size, growth pattern, nuclear atypia, and m itotic activity 5,10,16,17 jn ^ current study, an unfavorable prognosis corresponded with high stage, large tumor size, high grade of nuclear atypia, and high mitotic activity. The tubulocystic growth pattern corresponded with a better prognosis than the solid or mixed growth pat tern. A classification criterion for the prediction of prognosis from the CNR in 1988 that was based on stage and nuclear atypia appeared in a follow-up study to correctly classify 95% of the patients.
It has been m entioned in the American literature that CCAC of the vagina and cervix may occur at an older age, but this has attracted little attention since then.18 In a study by Kaminski and Maier from 1983, data were reported from 23 w om en with CCAC of the cervix who had not b een exposed to DES, and who varied in age from 13 to 80 years.19. In the current study the authors examined the occurrence of CCAC of the vagina or cervix diagnosed betw een 1988 and 1993 in the whole population, regardless of the w om en's age and history of DES exposure. The age distribu tion of the 64 patients with CCAC w ho were diagnosed since 1988 showed 2 clearly separated peaks. The first contained 30 young w om en with a m ean age of 26 years. The second contained 34 older w om en born before 1947, who had thus not been exposed to DES, with a m ean age of 71 years. The first peak contained all DES daughters. If the DES daughters were excluded, the age distribution still showed a bimodal pattern, with a first peak at age 2 5 -3 0 years. Such bim odal age distributions have been described for those types of cancer in which an important genetic factor has b een determined (e.g., retinoblastoma, medullary carci noma of the thyroid, and carcinoma o f the colon).20 Hereditary cases of carcinoma of the breast and ovary are strongly concentrated in the younger age group. 21 The authors' finding of a clearly bim odal age dis tribution in w om en with CCAC has not been described previously. In the hypothesis that a population at risk exists, the bimodal age distribution is characteristic for the existence of a subpopulation with a strongly increased risk. DES exposure, w hich is thus far, to the authors' knowledge, the only researched risk factor, appears to be a risk factor, but does not provide an explanation for the prom inent peak at a young age in w om en not exposed to DES. The maximum risks for non-DES-related CCAC thus occur at the ages of ap proxim ately 25 and 70 years, respectively. At least two explanations are possible: a risk period or a risk popu lation.
Risk period
An interval of 10 to 20 years after m enarche and m en o pause is in agreem ent with the estim ated evolution time betw een the m alignant transformation of the first cell and the diagnosis of several types of cancer such as carcinom a of the cervix. 22 The carcinogenic risk would thus strongly increase after the significant changes in the horm onal clim ate w ith the rise of the pituitary gonadotropin horm ones, luteinizing horm one and fol licle-stim ulating horm one, that mark the menarche and m enopause. The effects of this "hormone storm" could play a causal role. This hypothesis does not im pact on the distribution of the risk within the popula tion, and it is com patible w ith a low and hom ogeneous distributed risk, as w ell as w ith the existence of a sub population with a genetically or otherwise defined higher sensitivity for changes in the gonadotropin cli mate. Thus, in utero DES exposure w ould in both cases only increase an already existing risk of carcinogene sis. It is of clinical im portance that this hypothesis would predict an increased incidence of CCAC in p ost m enopausal DES exposed w om en. Continued surveil lance of these w om en after the age of 40 years would be warranted.
Risk population
Changes in the gonadotropin clim ate do not play a role in this hypothesis. The age peaks reflect two popu lations w ith a significantly different risk of CCAC. The highest num ber of w om en with a normal and low risk have a peak at older age, as is the case with most tumors w hose incidence rate increases with age due to cumulative risks. The peak at a younger age must then be explained by a subpopulation with increased risk. This risk is either constitutional (genetic or other wise), is based on exposure to exogenous agents other than DES, or a com bination of the tw o (e.g., a constitu tional sensitivity for carcinogens). In this hypothesis, DES could also increase an existing risk to develop CCAC at a young age. However, no increased inci dence of CCAC is then expected in postmenopausal DES-exposed w om en.
Thus in both the risk period and the risk popula tion hypotheses, factors other than DES also appear to play a role in the acceleration o f carcinogenesis in the group of younger patients. These may be other exogenous or genetic risk factors.
Recently a familial chrom osom e translocation has been described in chrom osom es 3 and 6 {46,XX,t(3;6)(q29;q23)} in both a mother and her DESexposed daughter. 23 The com bination of the use of DES by the m other and the presence of a familial chro m osom e translocation in both herself and her daugh ter may, according to Leschot, occur frequently.23 Elaborating on this, it m ay be possible that some of the chrom osom al changes that occur in some wom en with multiple miscarriages m ayb e linked to a potential for neoplastic transformation. A relationship between repeated spontaneous abortion, breast carcinoma, and an estrogen receptor gene variant has been de scribed.24,25 If a hypothesis concerning genetic factors for the occurrence of CCAC is supported, then the initiating neoplastic potential of DES should be recon sidered. Further research in this respect is necessary. Concentrating on DES as the only risk factor for CCAC may stand in the way of gaining increased knowledge of hormonal carcinogenesis. Although DES has not been prescribed to wom en during pregnancy in the Netherlands for almost 20 years, the problems related to intrauterine DES expo sure are still relevant. It is important to remain alert and to periodically update and evaluate the data of this registry, and to keep an open mind regarding the existence of additional or alternative risk factors. 26 
